Galectin Therapeutics



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 222.66M 97.54M 2025-03
Merck USD 7.74B 625M 2025-03



Galectin Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.